Alpha Growth PLC BlackOak Alpha Growth Fund Year End Results (7787L)
January 15 2021 - 1:00AM
UK Regulatory
TIDMALGW
RNS Number : 7787L
Alpha Growth PLC
15 January 2021
Alpha Growth Plc
("Alpha", or the "Company")
Life Settlement specialist Alpha Growth announces year end
results of BlackOak Alpha Growth Fund managed by the Group.
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), the financial
services specialist in the growing Senior Life Settlement ("SLS")
asset class, is pleased to announce the year end results for its
BlackOak Alpha Growth Fund (the "Fund") investing in SLS.
On a net basis, the Fund produced a 2020 calendar year return of
10.63% and a 13.71% total return since inception, September
2019.
Alpha continues to actively market to registered investment
advisors in the US and to look at supplementing the direct outreach
with virtual events in the US that showcase the Fund.
With its December listing on the OTCQB, Alpha intends to closely
coordinate the US marketing of the Fund with greater reference to
the Company so US investors are able to follow the holding company
of the General Partner and Investment Manager of the Fund as well.
The Directors believe that this will expand the interest of US
investors in the Company's shares.
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
For more information, please visit www.algwplc.com or contact
the following:
Alpha Growth Plc +44 (0) 20 3959 8600
Gobind Sahney, Executive Chairman info@algwplc.com
Pello Capital Limited +44 (0) 20 7710 9610
Mark Treharne mt@pellocapital.com
BlackOak Alpha Growth Funds +1 949-326-9799
Austin King, Investor Relations ak@algwplc.com
About Alpha Growth Plc
Specialist in Longevity Assets
Alpha Growth Plc is a financial advisory business providing
specialist consultancy, advisory, and supplementary services to
institutional and qualified investors globally in the multi-billion
dollar market of longevity assets. Building on its well-established
network, the Alpha Growth Group has a unique position in the
longevity asset services and investment business, as a listed
entity with global reach. The Group's strategy is to expand its
advisory and business services via acquisitions and joint ventures
in the UK and the US to attain commercial scale and provide
holistic solutions to alternative institutional investors who are
in need of specialised skills and unique access to deploy their
financial resource in longevity assets. www.algwplc.com .
SLS Assets and Non-correlation
A SLS refers to the sale of an existing life insurance policy to
a third party for a cash payment. Such a payment will be in excess
of the policy's surrender value, but less than its face value.
After the sale, the purchaser becomes the policy's beneficiary and
assumes payment of its premiums. There are many reasons why policy
holders may choose to sell their life insurance policies and sales
are usually only undertaken when the insured person doesn't have a
known life-threatening illness. The SLS provides individuals with
policies the option to realise value from an asset under a
regulated transaction. As a longevity asset, the SLS is
non-correlated to the real estate, equity capital and commodity
markets. Its value is a function of time because as time passes the
value gets closer to the face value of the policy. Hence creating a
steady increase in the net asset value of the investment. This
makes it highly attractive to investors wishing to counteract
volatility within an investment portfolio and add yield.
Note: The Company only advises on and manages SLS Assets that
originate in the USA where the SLS market is highly regulated.
About BlackOak Alpha Growth Fund
The Fund was established by two highly experienced longevity
asset management companies. The Fund invests in life settlements,
is a Cayman LP with a tax efficient Master/Feeder structure in an
open-ended format with quarterly redemptions. The Fund seeks to
provide well-diversified, non-correlated returns. The Fund aims to
achieve this objective through the acquisition of secondary and
tertiary Life Settlement policies that will be structured and
purchased to mitigate longevity risk and other investment and
business risks and where the Company's expertise can add value.
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEANFLFDSFEFA
(END) Dow Jones Newswires
January 15, 2021 02:00 ET (07:00 GMT)
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Apr 2023 to Apr 2024